Flurazepam Hydrochloride Cap · 1,500 days since initial FDA posting
FDA lists Flurazepam Hydrochloride Cap as Active Shortage (Rising Pharma Holdings, Inc.).
Availability on file: Unavailable
Flurazepam Hydrochloride Capsule: Active Shortage
Unavailable Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Flurazepam Hydrochloride Capsule
- Manufacturer
- Rising Pharma Holdings, Inc.
- Dosage Form
- Capsule
- Presentation
- Flurazepam Hydrochloride, Capsule, 15 mg (NDC 0378-4415-01)
- Package NDC
- 0378-4415-01
Status & Timeline
- Status
- Active Shortage
- Availability
- Unavailable
- First Reported
- Aug 3, 2022
- Last Updated
- Jan 14, 2026
- Therapeutic Category
- Neurology, Other
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Anticipated availability: Q4 2026; Delay is due to manufacturing delays at the contract manufacturing facility.
Nearby, Other Flurazepam Shortage Records
Flurazepam Hydrochloride Capsule
Chartwell Molecular Holdings LLC
Capsule
Flurazepam Hydrochloride Capsule
Chartwell Molecular Holdings LLC
Capsule
Flurazepam Hydrochloride Capsule
Chartwell Molecular Holdings LLC
Capsule
Flurazepam Hydrochloride Capsule
Chartwell Molecular Holdings LLC
Capsule
Flurazepam Hydrochloride Capsule
Rising Pharma Holdings, Inc.
Capsule
FDA reason on file: Anticipated availability: Q4 2026; Delay is due to manufacturing delays at the contract manufacturing facility. General shortage guidance lives on the tracker hub.